The reimbursement lists identifies pharmaceutical products that are subsidized under the current medical insurance system. If a drug is not on the list, the consumer has to pay for it with his own expenses. These lists were created to replace an inefficient reimbursement system through which anyone could be reimbursed for anything, and upon which pharmaceutical companies thrived for years.